137 related articles for article (PubMed ID: 1689429)
1. Acute hemodynamic effects of nilvadipine, a new calcium channel blocker, in patients with congestive heart failure.
Sato H; Ikenouchi H; Aoyagi T; Matsui H; Mochizuki T; Momomura S; Serizawa T; Iizuka M; Sugimoto T
J Cardiovasc Pharmacol; 1990 Feb; 15(2):317-22. PubMed ID: 1689429
[TBL] [Abstract][Full Text] [Related]
2. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
Olivari MT; Levine TB; Cohn JN
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
[TBL] [Abstract][Full Text] [Related]
3. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
[TBL] [Abstract][Full Text] [Related]
4. Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
Kiowski W; Erne P; Pfisterer M; Mueller J; Buehler FR; Burkart F
Am J Cardiol; 1987 May; 59(12):1118-25. PubMed ID: 3578053
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist.
Honerjäger P; Seibel K
J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S15-21. PubMed ID: 1283184
[TBL] [Abstract][Full Text] [Related]
6. Effects of a new second generation calcium channel blocker, nilvadipine (FR34235), on exercise-induced hemodynamic changes in stable angina pectoris.
Yokota M; Koide M; Miyahara T; Kamihara S; Tsunekawa A; Noda S; Sotobata I
J Am Coll Cardiol; 1987 Oct; 10(4):830-6. PubMed ID: 3655150
[TBL] [Abstract][Full Text] [Related]
7. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of nisoldipine in chronic congestive heart failure.
Vogt A; Kreuzer H
Arzneimittelforschung; 1983; 33(6):877-9. PubMed ID: 6684444
[TBL] [Abstract][Full Text] [Related]
9. Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
Kubo SH; Fox SC; Prida XE; Cody RJ
Am Heart J; 1985 Nov; 110(5):1032-4. PubMed ID: 3933315
[TBL] [Abstract][Full Text] [Related]
10. Nilvadipine: profile of a new calcium antagonist. An overview.
Rosenthal J
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
[TBL] [Abstract][Full Text] [Related]
11. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.
Elkayam U; Weber L; McKay CR; Rahimtoola SH
Am J Cardiol; 1984 Jul; 54(1):126-31. PubMed ID: 6741802
[TBL] [Abstract][Full Text] [Related]
12. Forearm venous distensibility in relation to severity of symptoms and hemodynamic data in patients with congestive heart failure.
Ikenouchi H; Iizuka M; Sato H; Momomura S; Serizawa T; Sugimoto T
Jpn Heart J; 1991 Jan; 32(1):17-34. PubMed ID: 2038122
[TBL] [Abstract][Full Text] [Related]
13. Effect of the second-generation calcium channel blocker nisoldipine on left ventricular contractility in cardiac failure.
Lewis BS; Shefer A; Merdler A; Flugelman MY; Hardoff R; Halon DA
Am Heart J; 1988 Jun; 115(6):1238-44. PubMed ID: 3376841
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.
Koseki N; Araie M; Tomidokoro A; Nagahara M; Hasegawa T; Tamaki Y; Yamamoto S
Ophthalmology; 2008 Nov; 115(11):2049-57. PubMed ID: 18672290
[TBL] [Abstract][Full Text] [Related]
15. Short-term and long-term hemodynamic and clinical effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure.
Kukin ML; Freudenberger RS; Mannino MM; Kalman J; Steinmetz M; Buchholz-Varley C; Ocampo ON
Am Heart J; 1999 Aug; 138(2 Pt 1):261-8. PubMed ID: 10426837
[TBL] [Abstract][Full Text] [Related]
16. Intravenous nisoldipine in severe congestive heart failure.
Moe GW; Karlinsky SJ; Frankel D; Armstrong PW
J Cardiovasc Pharmacol; 1988 Aug; 12(2):160-6. PubMed ID: 2459547
[TBL] [Abstract][Full Text] [Related]
17. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure.
Munger MA; Nara AR; Pospisil RA; Stoddard GJ; Schleman M
Pharmacotherapy; 1993; 13(3):218-23. PubMed ID: 8100627
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical effect of nilvadipine in patients with chronic heart failure: a double-blind placebo-controlled study.
Hori M; Sato H; Karita M; Kodama K; Hoki N; Hayashi T; Naka M; Nanto S; Yamada Y; Kamada T
Heart Vessels; 1994; 9(5):249-53. PubMed ID: 7814301
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the acute hemodynamic effect of nisoldipine (Bay k 5552) and nifedipine in patients with ischemia-induced left ventricular impaired function].
Aschenberg W; Nienaber C; Spielmann R; Bleifeld W
Z Kardiol; 1988 Apr; 77(4):238-44. PubMed ID: 3291444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
